GRNY Fundstrat Granny Shots US Large Cap ETF

Expense Ratio
0.75%
Previous close
$24.01
Est. 12 months change
+21.86%
Projected Price
$29.26

Profitability Metrics

Return on Equity (ROE)
33.29%
Return on Assets (ROA)
9.99%
Return on Invested Capital (ROIC)
36.01%
Weighted Average Cost of Capital (WACC)
9.77%
ROIC - WACC
26.24%
Updated : 2026-04-04 07:39 ET

Valuation Metrics

P/E Ratio
30.38
Forward P/E
17.47
PEG Ratio
2.10
Debt Current Ratio
2.06

Growth & Cash Flow

Gross Margin
50.56%
Operating Margin
25.67%
FCF Margin
20.74%
TTM Revenue Growth
17.49%
Projected 12M EPS Growth
73.89%

Price Change

Price % from 50 SMA
-2.83%
Price % from 200 SMA
-1.72%
6 Months
-5.02%
1 Year
28.81%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NFLX3.24%
CVX2.95%
TPL2.87%
GEV2.75%
PLTR2.74%
OKE2.72%
PWR2.70%
APD2.68%
AMD2.67%
AMZN2.65%

ETF Analysis

Fund Overview

Fundstrat Granny Shots US Large Cap ETF (GRNY) currently reports 41 stock positions (subject to change), placing it in the moderately diversified range by holdings breadth. The top line-up is NFLX (3.24%), CVX (2.95%), TPL (2.87%), with NFLX as the largest single weight at 3.24%. Together, the top three holdings account for 9.06%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 36.01%, WACC is 9.77%, and the economic spread is 26.24%. On balance, the portfolio's holdings exhibit an exceptional economic spread, compounding intrinsic value at a rate few funds can match. Supporting metrics show ROE at 33.29% and ROA at 9.99%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Multiple analysis puts the portfolio at trailing P/E of 30.38, forward P/E of 17.47, PEG of 2.10. The spread from trailing to forward multiple is wide enough to suggest earnings momentum is a meaningful part of the current valuation case. On a PEG basis, valuation is in the middle ground — fair for the growth on offer, with the return case resting on earnings delivery rather than re-rating. At 2.06, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The combined valuation and liquidity profile points to a portfolio where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.

Margins & Cash Generation

On the margin front: gross margin sits at 50.56%, operating margin at 25.67%, and free cash flow margin at 20.74%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. Operating margins sit in a healthy range — not exceptional, but indicating reasonable operational efficiency. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin trifecta here — strong at gross, operating, and free cash flow levels — is a hallmark of competitively advantaged businesses.

Growth & Forward Outlook

On the forward picture: TTM revenue growth of 17.49% reflecting consistent if unspectacular revenue expansion. Consensus EPS estimates point to 73.9% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.